Page last updated: 2024-08-21

indirubin and Carcinoma, Neuroendocrine

indirubin has been researched along with Carcinoma, Neuroendocrine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becher-Boveleth, N; Broecker-Preuss, M; Mann, K	1

Other Studies

1 other study(ies) available for indirubin and Carcinoma, Neuroendocrine

Article	Year
Cell Death Induction by the Indirubin Derivative 7BIO and the BH3 Mimetic Drugs ABT-737 and GX15-070 in Medullary Thyroid Carcinoma Cells. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2016, Volume: 124, Issue:5 Topics: BH3 Interacting Domain Death Agonist Protein; Biphenyl Compounds; Carcinoma, Neuroendocrine; Cell Death; Cell Line, Tumor; Humans; Indoles; Molecular Mimicry; Nitrophenols; Piperazines; Protein Kinase Inhibitors; Pyrroles; Sulfonamides; Thyroid Neoplasms	2016

Article

Year

Cell Death Induction by the Indirubin Derivative 7BIO and the BH3 Mimetic Drugs ABT-737 and GX15-070 in Medullary Thyroid Carcinoma Cells.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2016, Volume: 124, Issue:5

Topics: BH3 Interacting Domain Death Agonist Protein; Biphenyl Compounds; Carcinoma, Neuroendocrine; Cell Death; Cell Line, Tumor; Humans; Indoles; Molecular Mimicry; Nitrophenols; Piperazines; Protein Kinase Inhibitors; Pyrroles; Sulfonamides; Thyroid Neoplasms

2016